David Thomson

Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement

Patricia Woo, Nicholas Wilkinson, Anne‐Marie Prieur et al. · Arthritis Research & Therapy · 2005 · 209 citations · Full text

Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement

David Thomson, David A. Palma, Matthias Gückenberger et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 209 citations · Full text

Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck

David Thomson, Priyamal Silva, Kim Denton et al. · Head & Neck · 2013 · 103 citations · Full text

Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis

Claire Petit, Benjamin Lacas, Jean‐Pierre Pignon et al. · The Lancet Oncology · 2021 · 100 citations · Full text

Adaptive Radiotherapy, Advanced Head, Neck Cancer +6

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma

Anna Maria Tsakiroglou, Martin Fergie, Ken Oguejiofor et al. · British Journal of Cancer · 2019 · 49 citations · Full text